Unusual Volume At Biotech Stocks: Aastrom Biosciences (NASDAQ:ASTM), 22nd Century Group (NYSEMKT:XXII), Dyax Corp. (NASDAQ:DYAX), Exelixis (NASDAQ:EXEL)

Over the past few trading days, sleepy microcap Aastrom Biosciences Inc (NASDAQ:ASTM) has exploded from $3.88 3/19/14 to a peak of $6.24 after a positive article from respected analyst Jason Napodano. Seeking Alpha’s sophisticated readership is more than capable of analyzing Aastrom Biosciences Inc (NASDAQ:ASTM)’s balance sheet. Aastrom Biosciences Inc (NASDAQ:ASTM) stock performance was -15.21% in last session and finished the day at $4.18. Traded … Continue reading Unusual Volume At Biotech Stocks: Aastrom Biosciences (NASDAQ:ASTM), 22nd Century Group (NYSEMKT:XXII), Dyax Corp. (NASDAQ:DYAX), Exelixis (NASDAQ:EXEL)

Colin Pettis03/2703/27

Top Losers: Plug Power Inc. (NASDAQ:PLUG), Facebook Inc. (NASDAQ:FB), Exelixis (NASDAQ:EXEL), FuelCell Energy Inc. (NASDAQ:FCEL)

Plug Power Inc. (NASDAQ:PLUG) the fuel-cell maker was in the news again yesterday, after CEO Andy Marsh told MarketWatch that the company had “signed an additional order in North America with a global automaker. Plug Power Inc. (NASDAQ:PLUG) stock performance was -23.94% in last session and finished the day at $6.45. Traded volume was 119.25 million shares in the last session and the average volume … Continue reading Top Losers: Plug Power Inc. (NASDAQ:PLUG), Facebook Inc. (NASDAQ:FB), Exelixis (NASDAQ:EXEL), FuelCell Energy Inc. (NASDAQ:FCEL)

Kevin Long03/2703/27

Market Wrap Up: Exelixis, Inc. (NASDAQ:EXEL), Sirius XM Holdings Inc. (NASDAQ:SIRI), Genocea Biosciences, Inc. (NASDAQ:GNCA), People’s United Financial (NASDAQ:PBCT), Atlantic Tele-Network (NASDAQ:ATNI)

On Dec 15, Exelixis, Inc. (NASDAQ:EXEL) announced its collaborator Genentech, a member of the Roche Group, has completed the filing of its New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination with vemurafenib for previously untreated patients with unresectable locally advanced or metastatic melanoma harboring a BRAF V600 mutation. Exelixis, Inc. … Continue reading Market Wrap Up: Exelixis, Inc. (NASDAQ:EXEL), Sirius XM Holdings Inc. (NASDAQ:SIRI), Genocea Biosciences, Inc. (NASDAQ:GNCA), People’s United Financial (NASDAQ:PBCT), Atlantic Tele-Network (NASDAQ:ATNI)

Colin Pettis12/30

Investor’s Choice: Staples, Inc. (NASDAQ:SPLS), Exelixis, Inc. (NASDAQ:EXEL), NTT DOCOMO, Inc. (NYSE:DCM), Splunk, Inc. (NASDAQ:SPLK), Air Methods Corp. (NASDAQ:AIRM)

On Dec 22, Staples, Inc. (NASDAQ:SPLS) says nearly 1.2 million customer payment cards may have been exposed during a security breach earlier this year. The office supply retailer announced in October that it was looking into a potential credit card breach, adding to a long list of retailers recently hit by cyberattacks. Staples, Inc. (NASDAQ:SPLS) belongs to Services sector. Its net profit margin is 2.70% … Continue reading Investor’s Choice: Staples, Inc. (NASDAQ:SPLS), Exelixis, Inc. (NASDAQ:EXEL), NTT DOCOMO, Inc. (NYSE:DCM), Splunk, Inc. (NASDAQ:SPLK), Air Methods Corp. (NASDAQ:AIRM)

Chris Lewis12/26

Hot Alert: Transocean Ltd. (NYSE:RIG), Theravance Inc. (NASDAQ:THRX), Exelixis, Inc. (NASDAQ:EXEL), ABB Ltd. (NYSE:ABB), Sony Corp (ADR) (NYSE:SNE)

Transocean Ltd. (NYSE:RIG) on Nov. 9 reported a net loss attributable to controlling interest for the three months ended September 30, 2014 of $2.217 billion, or $6.12 per diluted share. For the three months ended September 30, 2013 the company reported net income attributable to controlling interest of $546 million, $1.50 per diluted share, which included net favorable items of $51 million, or $0.14 per … Continue reading Hot Alert: Transocean Ltd. (NYSE:RIG), Theravance Inc. (NASDAQ:THRX), Exelixis, Inc. (NASDAQ:EXEL), ABB Ltd. (NYSE:ABB), Sony Corp (ADR) (NYSE:SNE)

Kevin Long11/17